Congress scrambles for a new funding deal, a report details the financial impacts of a mandatory bundled payment model, and a woman receives a genetically modified pig kidney transplant.

Congress negotiates its year-end healthcare package, Dreamers lose access to ACA exchanges, and Elevance reverses its controversial anesthesia policy.

CMS proposes adding weight-loss drugs to Medicare coverage, Trump nominates more healthcare positions, and a study tracks widespread pharmacy closures.

Trump picks his healthcare cabinet nominees, PBMs sue the FTC over its insulin case, and controlled substance telehealth flexibilities are extended yet again.

DOJ sues to block UHG-Amedisys deal, Cigna quashes Humana merger talks, and Johnson & Johnson sues to revive its 340B rebate program.

CMS finalizes the 2025 OPPS rule, an appeals court rules reverses a No Surprises Act decision, and MACPAC calls for more Medicaid payment oversight.

Amazon and Cleveland Clinic announce an affiliation, Oracle unveils its new EHR, and semaglutide is almost off the drug shortages list.

The FTC finalizes its premerger notification rule, Walgreens announces over 1K closures, and providers win a large antitrust class action settlement.

VP Harris proposes that Medicare cover home health aides, four health systems launch a new company, and CMS releases its initial list for $2 generic drugs.

CMS raises the bar for MA plan quality ratings, CVS announces corporate layoffs, and California passes healthcare AI legislation.

FTC sues PBMs over insulin pricing, a House bill would extend telehealth flexibilities, and HRSA awards contracts for the new organ transplant system.

HRSA warns Johnson & Johnson over 340B restrictions, a group of hospitals sues HHS to overturn DSH payment changes, and a CHS subsidiary expands its urgent care network.